Dr. Michael Engelbert, MD

Dr. Engelbert practices at Vitreous Retina Macula Consultants of New York in New York, New York.

Dr. Engelbert's NPI, 1699945543, was assigned on March 6, 2008. Dr. Engelbert graduated from Ludwig Maximilian University of Munich Faculty of Medicine in 1999. Dr. Engelbert holds New York license 254183-1.

Dr. Engelbert's primary practice is Vitreous Retina Macula Consultants of New York, at 460 Park Ave, New York, NY 10022 in New York County. The practice phone is (212) 861-9797.

Dr. Engelbert's primary practice is Vitreous Retina Macula Consultants of New York in New York, New York. Dr. Engelbert is also affiliated with Lenox Hill Hospital. Dmand AI also links Dr. Engelbert to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Engelbert practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Engelbert's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Engelbert is licensed in New York.

CMS data shows 68,205 Medicare services from Dr. Engelbert across 17 procedure codes in 2024, for 1,378 Medicare patients. Medicare paid $2,687,070 for them.

CMS counts 1,378 Medicare patients who saw Dr. Engelbert in 2024. The largest group is 65 to 74, with 535 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Engelbert's median patient age at 65, with 51% women.

In 2024, Dr. Engelbert wrote 1,101 Medicare Part D claims for 373 patients. 52% of them were for generic drugs. CMS names the drug for 962 of them, across 22 drugs with 11 or more claims each, at $164,023 in total drug cost. In 2023, CMS named 663 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Engelbert for performance year 2024, reported as part of a group. Dr. Engelbert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of cataract surgery by Dr. Engelbert, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 46 papers to Dr. Engelbert, published from 2011 to 2023. 2015 was the busiest year, with 4. The most frequent topics are Tomography, Optical Coherence, Vitreous Body and Retinal Detachment. Dr. Engelbert has published most often in Retina. Dr. Engelbert's most frequent co-authors are Talia Rosenberg Kaden, MD, Kunal K. Dansingani, MD and Howard F. Fine, MD.

CMS Open Payments shows 274 general payments to Dr. Engelbert from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $107,371. It also lists 2 research payments totaling $1,417 in 2023.

Dr. Engelbert graduated from Ludwig Maximilian University of Munich Faculty of Medicine in 1999.